Proportion of Days Covered - Beta-Blockers (PDC-BB)

Count and percent of individuals ≥18 years of age who met the Proportion of Days Covered (PDC) threshold of 80% for beta-blockers during the measurement year.

  • A higher rate indicates better performance.

Measure Identifier: PHARM_PDC.04

Customize
View: Totals By Submitter      Trend type: Line Bar       Hide confidence intervals       Hide labels       Hide graphs       Hide tables
Print | PDF

Please see Report Details below for more information on selected subgroups, organizations, and aggregation.

Tables

Data


The following measures contain the HEDIS® Hospice Value Set that was developed, is owned by and is included with the permission of the National Committee for Quality Assurance (“NCQA”). The Healthcare Effectiveness Data and Information Set (HEDIS®) is a registered trademark of NCQA.

  • Proportion of Days Covered Composite (PDC-CMP)
  • Proportion of Days Covered: Diabetes All Class (PDC-DR) 
  • Proportion of Days Covered: Renin Angiotensin System Antagonists (PDC-RASA) 
  • Proportion of Days Covered: Statins (PDC-STA)
  • Proportion of Days Covered: Beta-Blockers (PDC-BB)
  • Proportion of Days Covered: Calcium Chanel Blockers (PDC-CCB) 
  • Adherence to Direct-Acting Oral Anticoagulants (PDC-DOAC) 
  • Adherence to Long-Acting Inhaled Bronchodilator Agents in COPD Patients (PDC-COPD) 
  • Proportion of Days Covered: Antiretroviral Medications (PDC-ARV) 
  • Adherence to Non-Infused Biologic Medications Used to Treat Rheumatoid Arthritis (PDC-RA) 
  • Adherence to Non-Infused Disease Modifying Agents Used to Treat Multiple Sclerosis (PDC-MS) 

 

Proprietary coding is contained in the HEDIS Hospice Value Set. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. NCQA disclaims all liability for use or accuracy of any coding contained in the HEDIS Hospice Value Set. The HEDIS Hospice Value Set is provided “as is” without warranty of any kind. Users shall not have the right to alter, enhance or otherwise modify the HEDIS Hospice Value Set, and shall not disassemble, recompile or reverse engineer the HEDIS Hospice Value Set. Anyone desiring to use the HEDIS Hospice Value Set within the measures without modification for an internal, non-commercial purpose or submitting measure rates to the Centers for Medicare & Medicaid Services or Integrated Healthcare Association may do so without obtaining any approval from NCQA. All other uses, including a commercial use, including but not limited to use by vendors calculating measure rates on behalf of a health plan or provider, or use of the HEDIS Value Set outside the measures, must be approved by NCQA and are subject to a license at the discretion of NCQA. ©2025 NCQA, all rights reserved. 

 

CPT Copyright 2025 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association. Applicable FARS/DFARS Restrictions Apply to Government Use. Fee Schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. PQA Measure Specifications 13 

COPYRIGHT 2025 PQA, INC. ALL RIGHTS RESERVED

Report Details

Generated on Aug 30 2026 at 23:08
Measures: Proportion of Days Covered - Beta-Blockers (PDC-BB)
Max Time Periods: 16
Organizations: All (aggregated)

Citation: NH Department of Health and Human Services. Bureau of Program Quality. Report generated on Aug 30 2026 at 23:08. [http://medicaidquality.nh.gov]

Disclaimer: While the NH Department of Health and Human Services - Bureau of Program Quality makes every effort to post accurate and reliable information, it does not guarantee or warrant that the information on this website is complete, accurate or up-to-date and assumes no responsibility for the use or application of any posted material.